Results 121 to 130 of about 3,598 (185)
Treatments for actinic prurigo: A case report with upadacitinib and systematic review. [PDF]
SAGE Open Med Case RepPerlmutter JW, Levy R, Sibbald C.
europepmc +1 more source
Mutation burden of narrowband ultraviolet B phototherapy (NB-UVB) in human skin: relevance to NB-UVB lifetime exposures and skin cancer surveillance. [PDF]
Br J DermatolFowler JC +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Documenta Ophthalmologica, 1983
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
C C, Sterk +2 more
exaly +3 more sources
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
C C, Sterk +2 more
exaly +3 more sources
PUVA therapy and the lens reconsidered
Documenta Ophthalmologica, 1988On the basis of animal experiments there appears to be a theoretical chance that lens changes will occur in patients receiving PUVA treatment. In the published studies the incidence of lens changes in patients treated with PUVA is very low. In this study changes were observed both during PUVA treatment and during a long follow-up period. The absence of
W L, Van Deenen, W P, Lamers
exaly +3 more sources
Successful Treatment of Scleroderma with PUVA Therapy
Journal of Dermatology, 1996AbstractPUVA therapy was carried out on four patients with scleroderma; three of them had cutaneous manifestations of progressive systemic sclerosis and one other exhibited generalized morphea. PUVA therapy was given with daily doses of 0.25 J/cm2 or 0.4 J/cm2 for 3–8 weeks, resulting in total doses between 3.5 J/cm2 and 9.6 J/cm2.
Takuro Kanekura
exaly +3 more sources
Journal of the American Academy of Dermatology, 2001
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire +2 more sources
Lichen aureus is one of the subtypes of a rare group of diseases, pigmented purpuric dermatoses. The natural course of the disease is slow evolution and slow resolution. Treatment is generally limited. We report a case of lichen aureus that responded dramatically to photochemotherapy (PUVA).
T C, Ling, V, Goulden, M J, Goodfield
openaire +2 more sources
OCULAR COMPLICATIONS OF PUVA THERAPY
Australasian Journal of Dermatology, 1993SummaryPUVA, the combination of psoralen and long wave ultraviolet radiation is widely used in the management of psoriasis, vitiligo and several other dermatological disorders. The potential for long term treatment to cause ocular damage remains to be determined and despite the large numbers of patients who have received PUVA treatment, development of ...
J A, See, P, Weller
openaire +2 more sources
Melanonychia associated with PUVA therapy
Journal of the American Academy of Dermatology, 2003We describe a case of melanonychia induced by PUVA. This phenomenon likely is more common than the few reports in the literature indicate.
Leslie S, Ledbetter, Sylvia, Hsu
openaire +2 more sources